Countries covered: United States
The US market for selected over-the-counter (OTC) drugs, at the manufacturer level, has been estimated at over $10 billion. This will increase to approximately $13 billion by 2007. Growth is expected to come from new switches and increased sales of allergy, cough, cold, and sinus and gastrointestinal products.
OTC drugs are becoming increasingly important in the US health care system. More than 80 therapeutic categories of OTC drugs are on the market, ranging from acne drugs to weight control products.
After lumbering along slowly for the past few years, the US market for prescription-to-OTC switches is expected to regain some of the momentum reminiscent of the mid-1990s. This industry guide addresses these market factors and their impact on the success of prescription-to-OTC switches, providing an overview of the top OTC companies and the marketing strategies they use to succeed in the OTC market. Finally, this guide presents a glimpse into the future with trends and products that will play an important role in how this market will evolve over the next 5-7 years.
The report's market and strategy review:
- Past switches
- Current switches
- Potential switch drugs and drug categories
- North American market for OTC and switched drugs
Drug categories reviewed:
- Allergic rhinitis
- Analgesics
- Asthma/respiratory conditions
- Benign prostatic hypertrophy
- Gastroesophageal reflux disease
- Glaucoma
- Hypertension
- Nicotine addiction
- Osteoporosis
An essential strategic resource, Theta’s Rx-to-OTC Switching: Market Issues & Strategies includes reviews and analyses of the following topics:
- Trends in the market for prescription-to-OTC switches
- Criteria for successful prescription-to-OTC switches
- Role of healthcare providers and payers in switch successes
- Impact of patent extensions and generic drugs in pharmaceutical marketing
- Major players and innovators in the OTC industry
Please Note: Theta requires that, for PDF orders, clients sign a confidentiality agreement prior to fulfillment of PDF email delivery.
Related Reports:
U.S. Overactive Bladder Market
Snapshots Hungary Pharmaceuticals 2009
Snapshots Venezuela Pharmaceuticals 2009
Snapshots Poland Pharmaceuticals 2009
Snapshots US Pharmaceuticals 2009
Mapping the Healthcare Landscape Bringing pharmaceuticals into focus
Snapshots US OTC Pharmaceuticals 2009
Snapshots US Nasal Products 2009
Snapshots South Africa Pharmaceuticals 2009
Snapshots Denmark OTC Pharmaceuticals 2009
|
(0 items)
